SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-022236
Filing Date
2024-05-09
Accepted
2024-05-09 16:13:01
Documents
52
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q advm-20240331.htm   iXBRL 10-Q 986900
2 EX-31.1 advm-20240331ex311.htm EX-31.1 10083
3 EX-31.2 advm-20240331ex312.htm EX-31.2 10104
4 EX-32.1 advm-20240331ex321.htm EX-32.1 5342
5 EX-32.2 advm-20240331ex322.htm EX-32.2 5340
  Complete submission text file 0001628280-24-022236.txt   3980891

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT advm-20240331.xsd EX-101.SCH 24145
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT advm-20240331_cal.xml EX-101.CAL 45404
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT advm-20240331_def.xml EX-101.DEF 95426
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT advm-20240331_lab.xml EX-101.LAB 402541
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT advm-20240331_pre.xml EX-101.PRE 254464
56 EXTRACTED XBRL INSTANCE DOCUMENT advm-20240331_htm.xml XML 335190
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36579 | Film No.: 24930755
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)